Since our public debut through the successful completion of our DeSPAC transaction, Alpha Modus has remained unwavering in its mission to drive long-term shareholder value through the strategic ...

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes ...